Vivo Bio Tech Ltd – Walk-Ins for Toxicology / Genetic Toxicology / Pathology / Analytical Chemistry / QAU / HRD / Freshers for All Departments on 8th July’ 2022

[ad_1]

Vivo Bio Tech Ltd is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD – GLP, AAALAC & IND guidelines. The company offers services in the areas of In vivo &In vitro toxicity studies, Pharmacological investigations, Pharmacokinetic & toxicokinetic studies, Genotoxicity screening, Analytical services etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules.

Walk In Drive at Vivo Bio Tech Ltd
Multiple Vacancies ( INCLUDES 25 For FRESHERS LIFE SCIENCES)
1. Toxicology-
M. sc. Life Sciences/ M. Pharm Pharmacology and Toxicology
3 to 5 Years Experience
Vacancies- 05

2. Genetic Toxicology
M. Sc. Life Sciences
3 to 5 Years Experience
Vacancies- 03
3. Analytical Chemistry
M. Sc. Life Sciences/ M. Pharm
3 to 5 Years Experience
Vacancies- 02
4. Pathology
M. Sc. Pathology
0 to 2 years experience
02 Vacancies

5. QAU
M. Sc. Life Sciences/ M. Pharm. Pharmacology and Toxicology
03 to 05 Years Experience
04 Vacancies
6. All Departments
M.Sc Life Sciences/ M. Pharm Pharmacology and Toxicology
Freshers
25 Vacancies

7. Pathology
B. Sc. MLT / DMLT
0 to 2 Years Experience
05 Vacancies
8. M. B. A. HR
0 to 2 Years Experience
01 Vacancy

Walk-In Date: 08-07-2022

Time: 10:00 AM to 3:00 PM

Venue: 

Vivo Bio Tech Ltd.

3 Floor, Ilyas Mohammed Khan Estate

# 8-2-672/ 5 & 6, Road No.1, Banjara Hills

Hyderabad – 500034,

Telangana, India

[ad_2]

Source link

Published by Pharma Jobs
Tell us something about yourself.

Posted

in

by

Tags:

Comments

0 responses to “Vivo Bio Tech Ltd – Walk-Ins for Toxicology / Genetic Toxicology / Pathology / Analytical Chemistry / QAU / HRD / Freshers for All Departments on 8th July’ 2022”

Get Connected!
Come and join Pharma Community. Expand your network in Pharma!

Comments

No comments yet